|
gptkbp:instanceOf
|
gptkb:medical_condition
|
|
gptkbp:alsoKnownAs
|
gptkb:syndrome_X
gptkb:insulin_resistance_syndrome
|
|
gptkbp:associatedWith
|
insulin resistance
chronic inflammation
|
|
gptkbp:cause
|
gptkb:kidney_disease
heart attack
stroke
early death
|
|
gptkbp:characterizedBy
|
high blood pressure
high blood sugar
low HDL cholesterol
abdominal obesity
high triglycerides
|
|
gptkbp:component
|
gptkb:HDL_cholesterol
blood pressure
triglycerides
waist circumference
fasting glucose
|
|
gptkbp:definedIn
|
gptkb:NCEP_ATP_III_criteria
gptkb:WHO_criteria
IDF criteria
|
|
gptkbp:diagnosedBy
|
clinical criteria
blood tests
|
|
gptkbp:firstDescribed
|
gptkb:Gerald_Reaven
1988
|
|
gptkbp:ICD-10_code
|
E88.81
|
|
gptkbp:managedBy
|
gptkb:metformin
gptkb:exercise
gptkb:food
weight loss
statins
antihypertensive drugs
|
|
gptkbp:prevalence
|
increases with age
20-25% of adults
higher in people with obesity
|
|
gptkbp:relatedTo
|
gptkb:polycystic_ovary_syndrome
gptkb:nonalcoholic_fatty_liver_disease
atherosclerosis
|
|
gptkbp:riskFactor
|
gptkb:cardiovascular_disease
gptkb:type_2_diabetes
genetic factors
smoking
sedentary lifestyle
unhealthy diet
|
|
gptkbp:symptom
|
often asymptomatic
|
|
gptkbp:treatment
|
gptkb:drug
lifestyle modification
|
|
gptkbp:bfsParent
|
gptkb:BMI
gptkb:Zyprexa
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
metabolic syndrome
|